How often should INTRASITE Gel be changed on a clean granulating wound? The European English instructions for use dated 03/2020, the only version this article covers, refuses to answer with a number: it states that on clean granulating wounds the frequency of dressing changes depends on the clinical condition of the wound and the amount of exudate produced. Everything below stays inside that document and the product it describes, and says nothing about hydrogel dressings as a category or about other versions.
Read that sentence as a sourcing specification rather than a clinical footnote: change frequency is not a property of the product, so it cannot be compared across brands, printed on an order form, or converted into a reorder rule. It is a reading taken at the bedside by the person doing the change.
What INTRASITE Gel Is, and What It Isn't
A gel-form hydrogel, sometimes called an amorphous hydrogel, is a shapeless hydrating gel: it has no geometry of its own, so it takes the shape of whatever wound bed it is put into. That is the first thing separating it from a sheet hydrogel, which is a pre-shaped, fixed-geometry dressing that stays where it is placed and comes off as one piece. It also separates it from a cream or an ointment, which are topical vehicles spread on skin rather than dressings that sit inside a wound and are later removed.
Form drives the whole frequency question. A sheet dressing has edges and a footprint, often an adhesive border, so its wear time is partly a mechanical story: does it still stick, has it rolled, is the border lifting. A gel has none of those failure modes. What it has is a volume of fluid sitting in the wound, and the question becomes how much of it is still doing work and how much the wound has already dealt with. That is a judgement, and judgements get made by a person looking at the wound.
Which is why the form has to be settled before anyone argues about intervals, and why comparing this gel with a sheet dressing on wear time fails: the two do not fail in the same way.
Why the IFU Won't Give You a Fixed Change Interval
If somebody quotes you a fixed change interval for INTRASITE Gel, that number did not come from this IFU. The 03/2020 European English IFU names two drivers, clinical condition and exudate, and stops there. The judgement holds only for this model, this version and this region; it says nothing about how a differently formulated gel behaves or how a current US pack is worded.
Clinical condition is the state of the wound visible at that moment: whether the bed is clean and granulating, granulation being the bumpy red tissue a healing wound bed shows, or whether something has changed since the last look. Exudate is the fluid the wound is producing, and amount is a bedside estimate rather than a laboratory value. Both are readings. Neither is a specification, and neither can be shipped in a carton.
For a purchasing reader the consequence is concrete: a product whose frequency is set by two readings taken at every change has to be bought against observed use, and its documentation should name who takes those readings, because that person is the real input to your reorder point.
Four Questions to Ask Before You Set a Schedule
What does the label actually say decides frequency? If the answer is exudate and clinical condition, then who reads the exudate at each change, and at what point in the change is that reading taken: before cleansing, after, or at the moment the old dressing comes off? Ask it that way and you have found the person your order quantity genuinely depends on, which is usually a nurse or a caregiver rather than a procurement system.
If clinical condition also drives the frequency, what changes in the buying decision when the condition changes? Sometimes nothing: the pack count stays flat and only the visit schedule moves. Sometimes the format changes, because a wound that has stopped producing much fluid may not need a gel in the bed at all. If the honest answer is that nothing changes in what you buy, then the interval was never a purchasing variable and you can stop trying to pin it down.
And if removal rather than absorption turns out to be the difficult part, does that change which wounds you should be sourcing this for in the first place? A product that goes in easily and comes out awkwardly is a different purchase depending on the geometry of the wound in front of you. Which lands on the question underneath the other three: are you buying a product with a schedule, or a product whose schedule is somebody's assessment? Those two purchases look identical on an invoice and behave nothing alike in a stockroom.
Three Wound Situations, Three Different Answers
Suppose three clinics order the same gel from the same line item and each has to decide when the next change happens.
First case: a clean granulating wound producing very little fluid. The exudate term barely moves between visits, so clinical condition is the term that decides timing, and whether the bed still looks clean and granulating is what triggers the next review. Second case: a clean granulating wound producing a lot of fluid. Same product, same sentence, different balance, because now exudate dominates, the dressing gets looked at sooner, and the buying pattern that follows is more units rather than a different interval written down anywhere.
Third case: a deep wound with a narrow opening, or a wound close to the eye. The IFU asks for care in the vicinity of the eyes, in deep wounds with narrow openings such as fistulae, and in body cavities where removal of the gel may be difficult. There the deciding variable is removal, not absorption, and removal is a plan somebody has to own before the product goes in. All three cases illustrate one driver each rather than a recommendation.
How Change Frequency Actually Gets Decided, Step by Step
Start with the pack in your hand. Confirm which product and which instruction version you are holding, because the document quoted here is the 03/2020 European English IFU and consistency with current US packaging has not been established; that is a sourcing check, not a clinical one. Then confirm the wound matches the statement you are relying on: the frequency sentence is written for clean granulating wounds, and a wound outside that description sits outside the sentence.
At each change, record what was observed, the exudate level and the condition of the wound bed, instead of holding a calendar interval. The record is what makes the next decision possible, and it is also what lets a buyer see real consumption instead of a guessed figure. When the dressing comes off, removal follows what the instructions state: the gel can be removed from the wound by rinsing with sterile saline solution. That is reported here rather than designed here, because the technique belongs to the care plan.
Finally, flag the situations the document singles out for care and route them to the treating clinician rather than to a purchasing decision. No soak time, no interval and no cleansing protocol is invented here, because the source does not provide them and a sourced blank beats a confident guess.
Who This Gel Is Not For
This is the wrong purchase for a buyer who needs one fixed number to paste into a standing order or a reorder rule, since the statement quoted here supplies no such number. It is also wrong for wounds outside the clean wound description in that sentence, and for deep narrow openings, body cavities or the area around the eye unless a clinician owns the removal plan, because those are exactly the places the instructions flag as needing care and potentially difficult gel removal.
It is the right purchase for a sourcing team or a caregiver buying a gel-form hydrogel against a care plan that already names who assesses exudate and clinical condition at each change, having first checked which regional pack version they are actually holding.
